A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A

Clinical trial NCT06222697 · RECRUITING

Trial details

NCT number: NCT06222697
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Hemophilia A Prophylaxis of Bleeding Treatment of Bleeding

Start date: 2024-01-24
Primary completion: 2028-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.